Publication Name	World Journal of Gastroenterology
Manuscript ID	25796
Country	Italy

Received	2016-03-23 08:52
Peer-Review Started	2016-03-23 14:29
To Make the First Decision	2016-05-12 14:37
Return for Revision	2016-05-12 15:36
Revised	2016-05-25 02:15
Second Decision	2016-06-06 08:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-06-15 18:47
Articles in Press	2016-06-15 18:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-07-08 17:05
Publish the Manuscript Online	2016-07-22 13:48

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Review
Article Title	Management of psoriasis patients with hepatitis B or hepatitis C virus infection
Manuscript Source	Invited Manuscript
All Author List	Claudio Bonifati, Viviana Lora, Dario Graceffa and Lorenzo Nosotti
Funding Agency and Grant Number
Corresponding Author	Claudio Bonifati, MD, Center for the Study and Treatment of Psoriasis San Gallicano Dermatologic Institute, IRCCS, ViaElioChianesi 53, 00144 Rome, Italy. psoriasi@ifo.it
Key Words	Psoriasis; Therapy; Conventional disease-modifying drugs; Biological disease-modifying drugs; Hepatitis B virus infection; Hepatitis C virus infection
Core Tip	At present, no guidelines give clear indications regarding the management of psoriasis patients with concomitant hepatitis B or hepatitis C virus infection who need a systemic treatment. On the basis of the available literature data, this paper provides an overview in this field from a practical point of view. A particular emphasis is given, with regard to the use of biological drugs, in the aforementioned patients.
Publish Date	2016-07-22 13:48
Citation	Bonifati C, Lora V, Graceffa D, Nosotti L. Management of psoriasis patients with hepatitis B or hepatitis C virus infection. World J Gastroenterol 2016; 22(28): 6444-6455
URL	http://www.wjgnet.com/1007-9327/full/v22/i28/6444.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i28.6444

Full Article (PDF)	WJG-22-6444.pdf
Full Article (Word)	WJG-22-6444.doc
Manuscript File	25796-Review.docx
Answering Reviewers	25796-Answering reviewers.pdf
Audio Core Tip	25796-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	25796-Conflict-of-interest statement.pdf
Copyright License Agreement	25796-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	25796-Language certificate.pdf
Peer-review Report	25796-Peer-review(s).pdf
Scientific Misconduct Check	25796-Scientific misconduct check.pdf
Scientific Editor Work List	25796-Scientific editor work list.pdf